SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001702447-20-000004
Filing Date
2020-04-22
Accepted
2020-04-22 17:37:58
Documents
1
Period of Report
2020-04-22

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3585
  Complete submission text file 0001702447-20-000004.txt   5102
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Issuer) CIK: 0001175680 (see all company filings)

IRS No.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1111 MAIN STREET SUITE 660 VANCOUVER WA 98660
Business Address
Patel Samir Rashmikant (Reporting) CIK: 0001702447 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-49908 | Film No.: 20808694